Targeting calcium handling in A-fib

The drug ent-verticilide reduced A-fib incidence and duration in an animal model, suggesting it may be a viable therapeutic option.

Study discovers that tumor mutation burden predicts survival outcome

The expected course of a patient’s cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD

Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.

Vanderbilt Patient-Reported Outcomes Measurement System collects millionth report

The Vanderbilt Patient-Reported Outcomes Measurement System has collected its millionth patient-reported outcome measure (PROM), or pre-appointment survey that patients complete about their health, making it one of the largest collections of such surveys in the United States.

Liquid biopsy test may detect early-stage and low DNA-shedding cancers

Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

VUMC app used by research participants around the world

MyCap is a secure, customizable mobile computing application (for smartphone or tablet) used to collect data from research participants on a remote basis.

At Vanderbilt University Medical Center, where MyCap was created and launched in 2018, some 107 projects have used the app, and by 2021, research participants in 135 countries had installed the free app.